Jan Aasly

21.1k total citations · 1 hit paper
182 papers, 6.7k citations indexed

About

Jan Aasly is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jan Aasly has authored 182 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Neurology, 53 papers in Molecular Biology and 49 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jan Aasly's work include Parkinson's Disease Mechanisms and Treatments (94 papers), Neurological disorders and treatments (32 papers) and Alzheimer's disease research and treatments (25 papers). Jan Aasly is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (94 papers), Neurological disorders and treatments (32 papers) and Alzheimer's disease research and treatments (25 papers). Jan Aasly collaborates with scholars based in Norway, United States and Canada. Jan Aasly's co-authors include Matthew J. Farrer, Linda R. White, Krisztina K. Johansen, Mathias Toft, Oliver Bandmann, Heather Mortiboys, Zbigniew K. Wszołek, Owen A. Ross, Mary Hulihan and Jennifer M. Kachergus and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Jan Aasly

181 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

2013 502 citations Joanne Trinh, Jan Aasly et al. Movement Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Aasly Norway	43	3.8k	2.2k	1.9k	1.8k	1.3k	182	6.7k
Huw R. Morris United Kingdom	47	4.5k 1.2×	1.7k 0.8×	1.9k 1.0×	1.6k 0.9×	1.3k 1.0×	204	7.2k
Marie‐Christine Chartier‐Harlin France	35	2.7k 0.7×	2.3k 1.1×	2.8k 1.5×	1.8k 1.0×	938 0.7×	88	6.0k
Takahiko Tokuda Japan	42	3.3k 0.9×	2.3k 1.0×	2.5k 1.3×	1.5k 0.8×	970 0.7×	171	6.9k
Justo Garcı́a de Yébenes Spain	42	4.5k 1.2×	1.6k 0.7×	1.9k 1.0×	3.2k 1.8×	1.1k 0.8×	144	7.2k
G. Meco Italy	42	4.7k 1.2×	1.6k 0.7×	1.0k 0.5×	2.4k 1.3×	1.2k 0.9×	122	6.7k
Lefkos Middleton United Kingdom	41	1.9k 0.5×	2.4k 1.1×	1.5k 0.8×	1.6k 0.9×	1.2k 0.9×	139	7.1k
Lorraine V. Kalia Canada	33	4.4k 1.2×	3.0k 1.4×	1.6k 0.8×	3.3k 1.8×	1.2k 0.9×	87	8.9k
Ekaterina Rogaeva Canada	53	3.4k 0.9×	3.6k 1.6×	3.4k 1.8×	1.6k 0.9×	1.4k 1.0×	188	8.3k
Michael D. Geschwind United States	41	3.1k 0.8×	3.7k 1.7×	1.2k 0.6×	1.6k 0.9×	1.5k 1.1×	132	7.4k
Rejko Krüger Germany	46	4.0k 1.1×	3.0k 1.4×	1.2k 0.6×	2.5k 1.4×	1.3k 1.0×	200	7.3k

Countries citing papers authored by Jan Aasly

Since Specialization

Citations

This map shows the geographic impact of Jan Aasly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Aasly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Aasly more than expected).

Fields of papers citing papers by Jan Aasly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Aasly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Aasly. The network helps show where Jan Aasly may publish in the future.

Co-authorship network of co-authors of Jan Aasly

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Aasly. A scholar is included among the top collaborators of Jan Aasly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Aasly. Jan Aasly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schaake, Susen, et al.. (2023). GBA1 in Parkinson’s disease: variant detection and pathogenicity scoring matters. BMC Genomics. 24(1). 322–322. 6 indexed citations

Delcambre, Sylvie, Jenny Ghelfi, Léa Grandmougin, et al.. (2020). Mitochondrial Mechanisms of LRRK2 G2019S Penetrance. Frontiers in Neurology. 11. 881–881. 22 indexed citations

Majbour, Nour K., Jan Aasly, Nishant N. Vaikath, et al.. (2020). CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers. Translational Neurodegeneration. 9(1). 15–15. 47 indexed citations

Loeffler, David A., Jan Aasly, Peter A. LeWitt, & Mary P. Coffey. (2019). What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?. Journal of Parkinson s Disease. 9(3). 467–488. 10 indexed citations

Loeffler, David A., Andrea C. Klaver, Mary P. Coffey, & Jan Aasly. (2018). Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal Aging. Frontiers in Aging Neuroscience. 10. 130–130. 12 indexed citations

Loeffler, David A., Andrea C. Klaver, Mary P. Coffey, Jan Aasly, & Peter A. LeWitt. (2016). Age-Related Decrease in Heat Shock 70-kDa Protein 8 in Cerebrospinal Fluid Is Associated with Increased Oxidative Stress. Frontiers in Aging Neuroscience. 8. 178–178. 16 indexed citations

Karlsson, M. K., Praveen Sharma, Jan Aasly, et al.. (2013). Found in transcription: Accurate Parkinson's disease classification in peripheral blood. Journal of Parkinson s Disease. 3(1). 19–29. 27 indexed citations

Sando, Sigrid Botne, Guro Berge, Jan Aasly, et al.. (2012). P3‐095: Changes in core biomarkers in cerebrospinal fluid and cognitive ability in patients with Alzheimer's disease: A two‐year longitudinal study. Alzheimer s & Dementia. 8(4S_Part_13). 1 indexed citations

Tzoulis, Charalampos, Gia Tuong Tran, Ivar Gjerde, et al.. (2011). Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene. Journal of Neurology. 259(2). 292–296. 25 indexed citations

10.

Johansen, Krisztina K., et al.. (2010). Genealogical studies in LRRK2-associated Parkinson’s disease in central Norway. Parkinsonism & Related Disorders. 16(8). 527–530. 15 indexed citations

11.

Sossi, Vesna, Raúl de la Fuente‐Fernández, Ramachandiran Nandhagopal, et al.. (2010). Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Movement Disorders. 25(16). 2717–2723. 88 indexed citations

12.

Larsen, Jan, Antonie Giæver Beiske, Svein Ivar Bekkelund, et al.. (2008). Motoriske symptomer ved Parkinsons sykdom. Tidsskrift for Den Norske Laegeforening. 2 indexed citations

13.

Myhre, Ronny, Mathias Toft, Jennifer M. Kachergus, et al.. (2008). Multiplealpha-synucleingene polymorphisms are associated with Parkinson’s disease in a Norwegian population. Acta Neurologica Scandinavica. 118(5). 320–327. 66 indexed citations

14.

Ross, Owen A., Kristoffer Haugarvoll, Jeremy T. Stone, et al.. (2007). Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism & Related Disorders. 13(7). 386–388. 4 indexed citations

15.

Toft, Mathias, Ignácio F. Mata, Owen A. Ross, et al.. (2007). Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease. Movement Disorders. 22(3). 389–392. 8 indexed citations

16.

Toft, Mathias & Jan Aasly. (2004). Genetikk ved Parkinsons sykdom. Tidsskrift for Den Norske Laegeforening.

17.

Mikkelsen, Gustav & Jan Aasly. (2004). Consequences of impaired data quality on information retrieval in electronic patient records. International Journal of Medical Informatics. 74(5). 387–394. 17 indexed citations

18.

Axelson, David E., et al.. (2002). Applications of neural network analyses to in vivo ¹H magnetic resonance spectroscopy of Parkinson disease patients. Journal of Magnetic Resonance Imaging. 16(1). 13–20. 19 indexed citations

19.

Aasly, Jan, O. P. van Diggelen, A. M. Boer, & Gunnar Brønstad. (2000). Phosphoglycerate kinase deficiency in two brothers with McArdle‐like clinical symptoms. European Journal of Neurology. 7(1). 111–113. 20 indexed citations

20.

Torbergsen, T., Erik Stålberg, Jan Aasly, & Sigurd Lindal. (1991). Myopathy in Marinesco-Sjögren syndrome: an electrophysiological study. Acta Neurologica Scandinavica. 84(2). 132–138. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact